Connecting to SEC EDGAR… PricingSign in
← All filings

RGEN

Repligen Corp SEC filings
Biological Products, (No Diagnostic Substances) · Nasdaq · Incorporated in DE
On the radar right now · 1
Nov 6, 4:02 PM ET
REPLIGEN CORPRGEN
Material agreement · New debt · Share sale (dilution)
Filing ↗
Filing history
2026-11-06
Current report 8-K
Material agreementNew debtShare sale (dilution)
Filing ↗
2026-10-30
Quarterly report 10-Q
Filing ↗
2026-10-30
Current report 8-K
Share sale (dilution)Other event
Filing ↗
2026-10-27
Current report 8-K
Earnings results
Filing ↗
2026-10-08
Insider trade 4
Filing ↗
2026-10-07
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-10-06
Insider trade 4
Filing ↗
2026-10-06
Current report 8-K
Acquisition/sale completedReg FD disclosure
Filing ↗
2026-10-05
Planned insider sale 144
Filing ↗
2026-10-05
Insider trade 4
Filing ↗
2026-10-05
Planned insider sale 144
Filing ↗
2026-09-30
425 425
Filing ↗
2026-09-28
Insider trade 4
Filing ↗
2026-09-25
Insider trade 4
Filing ↗
2026-09-24
Planned insider sale 144
Filing ↗
2026-09-22
Insider trade 4
Filing ↗
2026-09-21
Planned insider sale 144
Filing ↗
2026-09-15
Current report 8-K
Exec/director change
Filing ↗
2026-09-08
425 425
Filing ↗
2026-09-08
Current report 8-K
Other event
Filing ↗
2026-09-08
Insider trade 4
Filing ↗
2026-09-04
EFFECT EFFECT
Filing ↗
2026-09-04
Prospectus 424B3
Filing ↗
2026-09-04
Planned insider sale 144
Filing ↗
2026-09-04
S-4/A S-4/A
Filing ↗
2026-09-02
Insider trade 4
Filing ↗
2026-08-25
S-4 S-4
Filing ↗
2026-08-21
Insider trade 4
Filing ↗
2026-08-20
Planned insider sale 144
Filing ↗
2026-08-14
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-04
425 425
Filing ↗
2026-07-31
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-07-29
Quarterly report 10-Q
Filing ↗
2026-07-28
Current report 8-K
Earnings results
Filing ↗
2026-07-24
425 425
Filing ↗
2026-07-22
425 425
Filing ↗
2026-07-22
425 425
Filing ↗
2026-07-22
Current report 8-K
Material agreementEarnings resultsReg FD disclosureOther event
Filing ↗
2026-07-17
Insider trade 4
Filing ↗
2026-07-16
Planned insider sale 144
Filing ↗